Description

Valrest 125 ER (Divalproex Sodium) is a pharmaceutical-grade anticonvulsant and mood stabilizer. Each tablet contains 125 mg of Divalproex Sodium in an extended-release formulation, allowing for consistent plasma concentration throughout the day.

Key Features:

Extended-release for once or twice daily dosing

Controls epileptic seizures by stabilizing neuronal activity

Stabilizes mood in bipolar disorder

Prevents migraine attacks in susceptible patients

Minimizes peak-trough fluctuations and enhances tolerability

Composition:

Active Ingredient: Divalproex Sodium 125 mg

Excipients: Pharmaceutical-grade ER matrix ensuring controlled release and absorption

Usage Instructions

Dosage: Administer exactly as prescribed by a healthcare professional.

Timing: Take once or twice daily, preferably at the same time each day.

Administration: Swallow tablets whole with water; do not crush or chew.

Monitoring: Periodic blood tests may be required to assess liver function, platelets, and therapeutic levels.

Missed Dose: Take as soon as remembered; do not double the dose.

Important: Dosage adjustment is necessary for age, weight, and concurrent conditions.

Medicinal Advantages

Seizure control: Reduces frequency and severity of generalized, absence, and complex partial seizures

Mood stabilization: Effective in managing bipolar mania

Migraine prevention: Reduces recurrence and intensity of migraine attacks

Neuroprotective effects: Supports neuronal stability and reduces excitotoxicity

Evidence: Clinical studies show Divalproex Sodium is well-established for epilepsy and mood disorders, widely recommended by neurologists and psychiatrists.

Side Effects

Common side effects:

Nausea, vomiting, diarrhea

Drowsiness or dizziness

Tremors or mild hair thinning

Serious side effects (seek medical attention):

Liver dysfunction or jaundice

Pancreatitis (severe abdominal pain)

Blood disorders (low platelets or WBC)

Consult a healthcare professional before starting, and report any unusual symptoms promptly.